美国不当冠状动脉介入治疗的虚假索赔法案调查
US False Claims Act Investigations of Unnecessary Percutaneous Coronary Interventions.
机构信息
Department of Health Policy and Management, Emory University, Atlanta, Georgia.
Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, Connecticut.
出版信息
JAMA Intern Med. 2020 Nov 1;180(11):1534-1536. doi: 10.1001/jamainternmed.2020.2812.
Abstract
This case-control study assess the association of US False Claims Act investigations of the overuse of PCIs with PCI volumes.
摘要
本病例对照研究评估了美国虚假索赔法案对 PCI 过度使用的调查与 PCI 数量之间的关联。
相似文献
1
US False Claims Act Investigations of Unnecessary Percutaneous Coronary Interventions.美国不当冠状动脉介入治疗的虚假索赔法案调查
JAMA Intern Med. 2020 Nov 1;180(11):1534-1536. doi: 10.1001/jamainternmed.2020.2812.
2
Patterns of Institutional Review of Percutaneous Coronary Intervention Appropriateness and the Effect on Quality of Care and Clinical Outcomes.经皮冠状动脉介入治疗适宜性的机构审查模式及其对医疗质量和临床结局的影响。
JAMA Intern Med. 2015 Dec;175(12):1988-90. doi: 10.1001/jamainternmed.2015.6217.
3
Association of Statewide Certificate of Need Regulations With Percutaneous Coronary Intervention Appropriateness and Outcomes.全州需求证书监管规定与经皮冠状动脉介入术适宜性和结局的关联。
J Am Heart Assoc. 2019 Jan 22;8(2):e010373. doi: 10.1161/JAHA.118.010373.
4
Upcoding of Clinical Information to Meet Appropriate Use Criteria for Percutaneous Coronary Intervention.为符合经皮冠状动脉介入治疗的适当使用标准而对临床信息进行高编。
Circ Cardiovasc Qual Outcomes. 2019 Mar;12(3):e005025. doi: 10.1161/CIRCOUTCOMES.118.005025.
5
Hundreds of unnecessary surgeries were done by physician assistant in $150m fraud.医师助理在一项1.5亿美元的欺诈案中实施了数百例不必要的手术。
BMJ. 2015 Sep 29;351:h5192. doi: 10.1136/bmj.h5192.
6
Appropriate coronary artery bypass grafting use in the percutaneous coronary intervention era: are we finally making progress?经皮冠状动脉介入治疗时代合适的冠状动脉旁路移植术应用：我们最终是否取得了进展？
Semin Thorac Cardiovasc Surg. 2012 Winter;24(4):241-3. doi: 10.1053/j.semtcvs.2012.11.005.
7
Italian doctors face fraud and murder charges.意大利医生面临欺诈和谋杀指控。
Lancet. 2008 Jun 28;371(9631):2159. doi: 10.1016/s0140-6736(08)60935-6.
8
The false claims act and the eroding scienter in healthcare fraud litigation.《虚假索赔法》与医疗保健欺诈诉讼中逐渐削弱的明知故犯原则
Ann Health Law. 2011 Winter;20(1):49-76, 8 p preceding 1.
9
The False Claims Act and clinical laboratories.《虚假索赔法》与临床实验室
Clin Lab Manage Rev. 1993 Sep-Oct;7(5):442-5.
10
SCAI position statement concerning coverage policies for percutaneous coronary interventions based on the appropriate use criteria.心血管造影和介入学会（SCAI）关于基于适当使用标准的经皮冠状动脉介入治疗覆盖政策的立场声明。
Catheter Cardiovasc Interv. 2016 May;87(6):1127-9. doi: 10.1002/ccd.26499. Epub 2016 Mar 10.
引用本文的文献
1
Hospital ownership and admission rates from the emergency department, evidence from Florida.医院所有权与急诊科入院率：来自佛罗里达州的证据。
Health Serv Res. 2024 Apr;59(2):e14254. doi: 10.1111/1475-6773.14254. Epub 2023 Oct 24.
2
The diffusion of health care fraud: A bipartite network analysis.医疗保健欺诈的传播：一个双重网络分析。
Soc Sci Med. 2023 Jun;327:115927. doi: 10.1016/j.socscimed.2023.115927. Epub 2023 Apr 28.
3
Fraud Claims Filed Involving Practicing Ophthalmologists from 1985 Through 2020.1985年至2020年期间针对执业眼科医生的欺诈指控
Clin Ophthalmol. 2023 Jan 24;17:341-350. doi: 10.2147/OPTH.S397014. eCollection 2023.
Zotero 插件